Li-Ting Zheng, Kun Qian, Jun Zhang, Meng-Ting Liu, Yi Li and Li-Quan Yang
RSC Adv., 2025,15, 35336-35355
Abstract
We propose a computational framework to explore pocket-aware inhibitors targeting the J pocket of BTK kinase by integrating generative deep learning, molecular docking, and molecular dynamics simulations.
Anna P. Valaka, Hampus Nyström, Liliana Håversen, Carlos Benitez-Martin, Clara Schäfer, Woo Suk Jang, Alessandro Camponeschi, Joakim Andréasson, Jan Borén and Morten Grøtli
RSC Chem. Biol., 2025,6, 618-629
Abstract
Development of a novel fluorescent probe for endogenous BTK imaging using evobrutinib as a scaffold. Evo-2 enabled real-time visualisation of BTK dynamics in living cells while preserving its enzymatic activity.
Burcu Bestas, H. Yesid Estupiñán, Qing Wang, Shabnam Kharazi, Chenfei He, Dara K. Mohammad, Dhanu Gupta, Oscar P. B. Wiklander, Taavi Lehto, Karin E. Lundin, Anna Berglöf, Mikael C. I. Karlsson, Frank Abendroth, Samir El Andaloussi, Michael J. Gait, Matthew J. A. Wood, Christian J. Leumann, Dmitry A. Stetsenko, Robert Månsson, Jesper Wengel, Rula Zain and C. I. Edvard Smith
RSC Chem. Biol., 2025,6, 761-771
From themed collection:
Nucleic Acid Chemistry: celebrating Christian Leumann’s retirement
Abstract
Splice-switching oligonucleotides (SSOs) targeting BTK pre-mRNA offer a potential therapy for X-linked agammaglobulinemia (XLA). PMO-Pip6a conjugate treatment partially restores the B lineage phenotype, offering insights into splice correction in B cell maturation.
Sudhakar Tangallapalli, Rambabu Gundla, Kalyani Paidikondala, Soňa Gurská, Naveen Kumar Rampeesa, Sreenivasa Reddy Anugu, Petr Džubák, Marián Hajdúch, Viswanath Das and Naresh Kumar Katari
RSC Adv., 2025,15, 47565-47586
Abstract
This study reports the design, synthesis, and biological evaluation of a novel series of 3-oxo-2,3-dihydropyridazine derivatives for selective inhibition of ITK, with potential application in T-cell leukemia treatment.
Sijun Pan, Aixiang Ding, Yisi Li, Yaxin Sun, Yueqin Zhan, Zhenkun Ye, Ning Song, Bo Peng, Lin Li, Wei Huang and Huilin Shao
Chem. Soc. Rev., 2023,52, 5706-5743
Abstract
Integrated development of designer chemical tools and complementary analytical technologies empowers new scientific and clinical opportunities.